


Capital appreciation.
| Name | % Net Assets | 
|---|---|
| Pfizer | 4.4% | 
| US Treasury N/B 0.875% 2016-11-30 | 3.6% | 
| US Treasury N/B 0.375% 2015-03-15 | 3.6% | 
| Aviva | 3.1% | 
| BT Group | 3.1% | 
| Sumitomo Mitsui Financial Group | 3.1% | 
| Sara Lee | 2.9% | 
| Pearson | 2.5% | 
| Royal Bank of Scotland | 2.3% | 
| Nippon Telegraph and Telephone | 2.3% | 
| Key | % Net Assets | 
|---|---|
| 4.4% | |
| 3.6% | |
| 3.6% | |
| 3.1% | |
| 85.3% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 4,473.85p | 
| Currency | GBP | 
| Change | -41.20p | 
| % | -0.91% | 
| YTD change | -138.28p | 
| YTD % | -3.00% | 
| Fund Inception | 09/01/1984 | 
|---|---|
| Fund Manager | Andrew Green | 
| TER | 1.70 (31-Dec-2010) | 
| Minimum Investment | |
|---|---|
| Initial | £6000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.35% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.09 | 
You are here: research